Analysis

FedEx (FDX) holds steady despite freight market slowdown

FedEx Corporation's (NYSE: FDX) second-quarter report underscored its resilience in a challenging market environment characterized by uneven demand, tariff tensions, and rising

Here’s how KB Home (KBH) is navigating a challenging housing market

Shares of KB Home (NYSE: KBH) fell 8% on Friday. The company reported its earnings results for the fourth quarter of 2025

Key takeaways from Micron’s (MU) first-quarter 2026 results

Micron Technology Inc. (NASDAQ: MU) has reported blockbuster first-quarter results, comfortably beating estimates as strength in data center demand pushed key operating

Interviews

AlphaStreet's dedicated Earnings Call section is your one-source destination for all publicly listed earnings conference calls. Listen to CEOs/CFOs discuss their company's earnings reports while Wall Street Analysts ask (or grill) with their hard hitting questions.

Most Read

CCL Earnings: Highlights of Carnival Corporation’s Q4 2025 results

Cruise operator Carnival Corporation & plc (NYSE: CCL) on Friday reported an increase in revenue and adjusted earnings for the fourth quarter of fiscal 2025. Earnings topped analysts' expectations. Revenues

December 19, 2025

Lamb Weston (LW) Q2 2026 Earnings: Key financials and quarterly highlights

Lamb Weston Holdings, Inc. (NYSE: LW) reported its second quarter 2026 earnings results today. Net sales inched up 1% year-over-year to $1.62 billion. Net sales at constant currency remained flat.

December 19, 2025

Paychex reports higher Q2 FY26 revenue and earnings; EPS beats estimates

Paychex Inc. (NASDAQ: PAYX) on Friday reported stronger-than-expected adjusted earnings for the second quarter of fiscal 2026. Revenues grew 18% year-over-year. The Rochester-based human capital management solutions provider reported revenues

December 19, 2025

Research Summary

SentinelOne, Inc. (NYSE: S) Research Summary

SentinelOne, Inc. (NYSE: S) is a leading cybersecurity company that offers advanced threat protection

Ocean Biomedical (NASDAQ: OCEA) Research Summary

Ocean Biomedical, Inc. (NASDAQ: OCEA) is a preclinical biotech company focused on moving new

Viewing Highlight
Loading...
Highlight
Close
Top